Brenda D. Jamerson, PharmD: Effect of Bupropion SR on Specific Symptom Clusters of Depression: Analysis of the 31-Item Hamilton Rating Scale for Depression

Name: Brenda D. Jamerson, PharmD: Effect of Bupropion SR on Specific Symptom Clusters of Depression: Analysis of the 31-Item Hamilton Rating Scale for Depression
SKU: 2991
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 37 No. 2 Articles Tags: alok-krishen, antidepressants, brenda-d-jamerson, chb, domains, jack-g-modell, jeremy-roberts, k-ranga-rama-krishnan, pharmd, principal-component-analysis, psychometrics, symptom-clusters

Description

Brenda D. Jamerson, PharmD: Effect of Bupropion SR on Specific Symptom Clusters of Depression: Analysis of the 31-Item Hamilton Rating Scale for Depression

Description

Brenda D. Jamerson, PharmD

EVIDENCE-BASED MEDICINE

Effect of Bupropion SR on Specific Symptom Clusters of Depression: Analysis of the 31-Item Hamilton Rating Scale for Depression

Brenda D. Jamerson, PharmD, K. Ranga Rama Krishnan, MB, ChB, Jeremy Roberts, MS, Alok Krishen, MSc, MS, and Jack G. Modell, MD

Are SNRIs More Effective than SSRIs? A Review of the Current State of the Controversy

Jane P. Gagliardi, MD: Evidence for the Treatment of Borderline Personality Disorder

Roland Kuhn-100th Birthday of an Innovator of Clinical Psychopharmacology

Generalized Anxiety Disorder: Raising the Expectations of Treatment

Brenda D. Jamerson, PharmD: Effect of Bupropion SR on Specific Symptom Clusters of Depression: Analysis of the 31-Item Hamilton Rating Scale for Depression

Description

Brenda D. Jamerson, PharmD

EVIDENCE-BASED MEDICINE

Effect of Bupropion SR on Specific Symptom Clusters of Depression: Analysis of the 31-Item Hamilton Rating Scale for Depression

Brenda D. Jamerson, PharmD, K. Ranga Rama Krishnan, MB, ChB, Jeremy Roberts, MS, Alok Krishen, MSc, MS, and Jack G. Modell, MD

Related products

Are SNRIs More Effective than SSRIs? A Review of the Current State of the Controversy

Jane P. Gagliardi, MD: Evidence for the Treatment of Borderline Personality Disorder

Roland Kuhn-100th Birthday of an Innovator of Clinical Psychopharmacology

Generalized Anxiety Disorder: Raising the Expectations of Treatment